Russia’s Sputnik V vaccine is 91.6% effective against coronavirus when two doses are given, according to peer-reviewed interim results from its phase three trial.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.


